United Capital Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$55.7M Buy
60,590
+264
+0.4% +$268K 0.34% 55
2025
Q4
$64.8M Buy
60,326
+3,262
+6% +$3.12M 0.39% 47
2025
Q3
$43.5M Buy
57,064
+3,942
+7% +$2.93M 0.31% 67
2025
Q2
$41.4M Buy
53,122
+2,794
+6% +$2.17M 0.33% 68
2025
Q1
$41.6M Buy
50,328
+5,603
+13% +$4.66M 0.36% 59
2024
Q4
$34.5M Buy
44,725
+117
+0.3% +$96.9K 0.29% 76
2024
Q3
$39.5M Buy
44,608
+4,076
+10% +$3.66M 0.33% 68
2024
Q2
$36.7M Sell
40,532
-84
-0.2% -$67.2K 0.32% 65
2024
Q1
$31.6M Buy
40,616
+1,873
+5% +$1.33M 0.26% 87
2023
Q4
$22.6M Buy
38,743
+11,680
+43% +$6.82M 0.19% 114
2023
Q3
$14.5M Sell
27,063
-1,977
-7% -$1.02M 0.1% 182
2023
Q2
$13.6M Sell
29,040
-4,130
-12% -$1.73M 0.07% 203
2023
Q1
$11.4M Sell
33,170
-10,656
-24% -$3.59M 0.06% 221
2022
Q4
$16M Sell
43,826
-3,602
-8% -$1.28M 0.09% 192
2022
Q3
$15.3M Sell
47,428
-4,460
-9% -$1.41M 0.09% 192
2022
Q2
$16.8M Sell
51,888
-122
-0.2% -$36.6K 0.09% 192
2022
Q1
$14.9M Sell
52,010
-10,631
-17% -$2.74M 0.07% 221
2021
Q4
$17.3M Buy
62,641
+1,132
+2% +$287K 0.08% 217
2021
Q3
$14.2M Sell
61,509
-425
-0.7% -$105K 0.07% 232
2021
Q2
$14.2M Buy
61,934
+11,629
+23% +$2.34M 0.07% 234
2021
Q1
$9.4M Sell
50,305
-44
-0.1% -$8.61K 0.05% 269
2020
Q4
$8.5M Buy
50,349
+1,852
+4% +$277K 0.05% 274
2020
Q3
$7.18M Sell
48,497
-1,123
-2% -$174K 0.05% 282
2020
Q2
$8.15M Sell
49,620
-2,140
-4% -$328K 0.06% 285
2020
Q1
$7.18M Sell
51,760
-11,720
-18% -$1.61M 0.06% 282
2019
Q4
$8.34M Buy
63,480
+14,191
+29% +$1.64M 0.05% 330
2019
Q3
$5.51M Sell
49,289
-28,031
-36% -$3.12M 0.04% 384
2019
Q2
$8.57M Sell
77,320
-8,191
-10% -$965K 0.06% 320
2019
Q1
$11.1M Buy
85,511
+1,142
+1% +$139K 0.08% 278
2018
Q4
$9.76M Buy
84,369
+22,625
+37% +$2.53M 0.08% 259
2018
Q3
$6.63M Sell
61,744
-454
-0.7% -$45.4K 0.05% 382
2018
Q2
$5.31M Sell
62,198
-2,985
-5% -$245K 0.04% 409
2018
Q1
$5.04M Buy
65,183
+1,819
+3% +$146K 0.04% 412
2017
Q4
$5.35M Sell
63,364
-2,268
-3% -$193K 0.04% 397
2017
Q3
$5.61M Sell
65,632
-4,919
-7% -$403K 0.05% 371
2017
Q2
$5.81M Buy
70,551
+423
+0.6% +$34.5K 0.05% 357
2017
Q1
$5.9M Sell
70,128
-3,058
-4% -$245K 0.06% 344
2016
Q4
$5.38M Sell
73,186
-96,228
-57% -$7.17M 0.05% 358
2016
Q3
$13.6M Buy
169,414
+17,528
+12% +$1.4M 0.13% 178
2016
Q2
$12M Sell
151,886
-534
-0.4% -$40.2K 0.12% 179
2016
Q1
$11M Buy
152,420
+2,800
+2% +$212K 0.12% 180
2015
Q4
$12.6M Sell
149,620
-7,447
-5% -$618K 0.15% 154
2015
Q3
$13.1M Sell
157,067
-3,352
-2% -$283K 0.16% 140
2015
Q2
$13.4M Buy
160,419
+11,744
+8% +$895K 0.16% 153
2015
Q1
$10.7M Buy
148,675
+114,338
+333% +$8.14M 0.13% 197
2014
Q4
$2.37M Buy
34,337
+3,810
+12% +$257K 0.04% 427
2014
Q3
$1.98M Buy
30,527
+753
+3% +$47.7K 0.03% 441
2014
Q2
$1.85M Buy
29,774
+2,444
+9% +$146K 0.03% 431
2014
Q1
$1.61M Buy
27,330
+12,644
+86% +$706K 0.03% 395
2013
Q4
$749K Sell
14,686
-99,747
-87% -$4.99M 0.03% 372
2013
Q3
$5.76M Sell
114,433
-13,343
-10% -$699K 0.18% 122
2013
Q2
$6.28M Buy
+127,776
New +$6.95M 0.17% 156

Other funds holding LLY

United Capital Financial Advisors's LLY Position: Q1 2026 in Review

United Capital Financial Advisors increased its Eli Lilly (LLY) stake by 0.44% in Q1 2026, buying an estimated $268K and bringing the position to 60,590 shares worth $55.7M. The position accounts for 0.34% of the portfolio, ranked #55.

United Capital Financial Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $64.8M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • United Capital Financial Advisors held 60,590 shares of Eli Lilly worth $55.7M as of Q1 2026.
  • United Capital Financial Advisors bought 264 Eli Lilly shares in Q1 2026, an estimated $268K.
  • Eli Lilly made up 0.34% of United Capital Financial Advisors's portfolio in Q1 2026, its #55 holding.
  • United Capital Financial Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • United Capital Financial Advisors's Eli Lilly position peaked at $64.8M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on United Capital Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.